Items tagged with Drug-resistant TB
Webinar: Debate on the future of treatment for drug-resistant TB (post)
So far, different standardised regimens are prescribed according to the status of the patient (new or previously treated) and/or the resistance of the bacilli: the cascade approach. These days, the TB drug pipeline is the best it has been for at least the last decade and there are currently numerous clinical trials underway looking at new drugs and new combinations for the treatment of TB. Does this re-invigorated drug pipeline allow for a change in approach to the management of drug-resistant TB moving away from the cascade approach to using the strongest possible regimens in the initial treatment of drug-resistant TB?
Old TB treatments result in deafness and death (post)
At the Union Conference on Tuberculosis and Lung Disease held in The Hague recently, a well-known European research clinician proclaimed that “countries (with weak health systems) should not let bedaquiline out of the box”.
Patna teen who fought to get TB care in Mumbai, dies (post)
The girl was brought to Mumbai in a state of being unable to breath and with an oxygen cylinder owing to scarring in her lungs. The extreme delay in treatment caused severe damage to her lungs, resulting in her death.
PNG based job opportunities: TB Medical Specialists for 2019 (post)
The Burnet Institute is currently looking for suitably qualified and experienced TB Medical Specialists to work with the Burnet based in Papua New Guinea (PNG).
India: Lack of digital ECGs slows roll-out of anti-TB drug (post)
The roll-out of crucial anti-tuberculosis drug, Bedaquiline is slow because of a substantial lack of digital electrocardiogram (ECG) machines on field.
Webinar: Introduction of the Nursing Guide for Managing Side Effects to Drug-resistant TB Treatment (post)
RESIST-TB and The Union’s Nurses and Allied Professionals Sub-Section (NAPS) will host a webinar on 16 January 2019 to discuss the Nursing Guide for Managing Side Effects to Drug-resistant TB Treatment, developed by the Curry International Tuberculosis Center (CITC) and the International Council of Nurses (ICN).
The evolution of TB treatment in India (post)
"... the need of the hour is to expand access to treatment for the most vulnerable subset of multidrug-resistant TB patients and ensure the judicious use of antibiotics in the public and private sector, while maintaining the level of funding required to tackle the growing threat of drug-resistant TB."
Study sheds more light on delamanid role in treating MDR-TB (post)
A phase 3 trial of delamanid, a newer oral drug for treating multidrug-resistant tuberculosis (MDR-TB), found no statistically significant reduction in time to sputum culture conversion when compared to placebo, but that it was safe and well tolerated.
How we used computers to figure out drugs that can beat drug-resistant TB (post)
Tuberculosis (TB) is one of the leading causes of death from infectious diseases. Globally, it accounts for around 1.3 million deaths and 10.4 million people develop the disease every year.
Sewri TB hospital starts giving bedaquiline to outpatients (post)
In an attempt to prioritise the comfort of patients suffering from tuberculosis, the civic-run TB hospital in Sewri has started giving bedaquiline in the outpatient department (OPD).
Page 56 of 117 · Total posts: 0
←First 55 56 57 Last→